ES2139081T3 - Composiciones farmaceuticas que contienen la hormona humana del crecimiento. - Google Patents
Composiciones farmaceuticas que contienen la hormona humana del crecimiento.Info
- Publication number
- ES2139081T3 ES2139081T3 ES94920573T ES94920573T ES2139081T3 ES 2139081 T3 ES2139081 T3 ES 2139081T3 ES 94920573 T ES94920573 T ES 94920573T ES 94920573 T ES94920573 T ES 94920573T ES 2139081 T3 ES2139081 T3 ES 2139081T3
- Authority
- ES
- Spain
- Prior art keywords
- growth
- contain
- pharmaceutical compositions
- pct
- human hormone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH] (Somatotropin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94920573A EP0804223B1 (en) | 1994-06-17 | 1994-06-17 | Hgh containing pharmaceutical compositions |
PCT/IT1994/000086 WO1995035116A1 (en) | 1994-06-17 | 1994-06-17 | Hgh containing pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2139081T3 true ES2139081T3 (es) | 2000-02-01 |
Family
ID=11332180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94920573T Expired - Lifetime ES2139081T3 (es) | 1994-06-17 | 1994-06-17 | Composiciones farmaceuticas que contienen la hormona humana del crecimiento. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5898030A (es) |
EP (1) | EP0804223B1 (es) |
JP (1) | JP3829991B2 (es) |
AT (1) | ATE184798T1 (es) |
DE (1) | DE69420872T2 (es) |
DK (1) | DK0804223T3 (es) |
ES (1) | ES2139081T3 (es) |
GR (1) | GR3031687T3 (es) |
WO (1) | WO1995035116A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070179096A1 (en) | 1996-04-24 | 2007-08-02 | Novo Nordisk A/S | Pharmaceutical Formulation |
EP1064934A1 (en) | 1999-06-30 | 2001-01-03 | Applied Research Systems ARS Holding N.V. | GRF-containing lyophilized pharmaceutical composition |
JP4711520B2 (ja) * | 2000-03-21 | 2011-06-29 | 日本ケミカルリサーチ株式会社 | 生理活性ペプチド含有粉末 |
AU8111301A (en) * | 2000-08-07 | 2002-02-18 | Inhale Therapeutic Syst | Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation |
WO2002092619A2 (en) | 2001-05-14 | 2002-11-21 | The Gouvernment Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Modified growth hormone |
US7026354B2 (en) * | 2001-10-02 | 2006-04-11 | Kimberly-Clark Worldwide, Inc. | Aromatic compositions for the inhibition of exoprotein production from gram positive bacteria |
US7022333B2 (en) * | 2001-10-02 | 2006-04-04 | Kimberly-Clark Worldwide, Inc. | Inhibition of exoprotein production in non-absorbent articles uisng aromatic compositions |
CA2516314C (en) * | 2003-03-18 | 2012-01-03 | Ares Trading Sa | Liquid growth hormone formulation and process of preparation thereof |
FR2873695A1 (fr) * | 2004-07-30 | 2006-02-03 | Palumed Sa | Molecules hybrides qa ou q est une aminoquinoleine et a est un antibiotique ou un inhibiteur de resistance), leur synthese et leurs utilisations en tant qu'agent antibacterien |
US20060067991A1 (en) * | 2004-09-30 | 2006-03-30 | Kimberly-Clark Worldwide, Inc. | Non-absorbent articles for inhibiting the production of exoproteins |
US20060067990A1 (en) * | 2004-09-30 | 2006-03-30 | Kimberly-Clark Worldwide, Inc. | Absorbent articles for inhibiting the production of exoproteins |
AU2005322019B2 (en) * | 2004-12-22 | 2010-08-26 | Ambrx, Inc. | Formulations of human growth hormone comprising a non-naturally encoded amino acid |
CN101523143A (zh) * | 2006-10-03 | 2009-09-02 | 惠氏公司 | 冻干方法和装置 |
DK2486916T3 (en) * | 2006-12-18 | 2015-06-15 | Ajinomoto Althea Inc | Formulations of Human Growth Hormone |
US20080260820A1 (en) * | 2007-04-19 | 2008-10-23 | Gilles Borrelly | Oral dosage formulations of protease-resistant polypeptides |
JP5924343B2 (ja) * | 2010-09-21 | 2016-05-25 | フェリング ベスローテン フェンノートシャップ | 組換えヒト成長ホルモン産生の改善された方法 |
AU2015358890B2 (en) * | 2014-12-10 | 2019-06-13 | Opko Biologics Ltd. | Methods of producing long acting CTP-modified growth hormone polypeptides |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4786501A (en) * | 1985-07-15 | 1988-11-22 | International Minerals & Chemical Corp. | Cylindrical implants for the controlled release of growth hormones |
ES2044941T5 (es) * | 1987-08-21 | 1999-02-16 | Mallinckrodt Group Inc | Estabilizador de hormonas promotoras del crecimiento. |
US5096885A (en) * | 1988-04-15 | 1992-03-17 | Genentech, Inc. | Human growth hormone formulation |
US5122367A (en) * | 1989-03-31 | 1992-06-16 | Massachusetts Institute Of Technology | Polyanhydride bioerodible controlled release implants for administration of stabilized growth hormone |
JP2950617B2 (ja) * | 1991-12-20 | 1999-09-20 | ノボ ノルディスク アクティーゼルスカブ | 成長ホルモンおよびヒスチジンを含んでなる安定化医薬製剤 |
CA2133737A1 (en) * | 1992-04-07 | 1993-10-14 | James E. Seely | Lyophilized somatotropin formulations |
IL106524A (en) * | 1992-07-31 | 2000-08-31 | Genentech Inc | Human growth hormone aqueous formulation |
EP1326439B1 (en) * | 2001-12-19 | 2009-07-29 | Alps Electric Co., Ltd. | Television tuner unit |
-
1994
- 1994-06-17 DE DE69420872T patent/DE69420872T2/de not_active Expired - Lifetime
- 1994-06-17 AT AT94920573T patent/ATE184798T1/de active
- 1994-06-17 US US08/750,684 patent/US5898030A/en not_active Expired - Lifetime
- 1994-06-17 ES ES94920573T patent/ES2139081T3/es not_active Expired - Lifetime
- 1994-06-17 DK DK94920573T patent/DK0804223T3/da active
- 1994-06-17 JP JP50190396A patent/JP3829991B2/ja not_active Expired - Lifetime
- 1994-06-17 EP EP94920573A patent/EP0804223B1/en not_active Expired - Lifetime
- 1994-06-17 WO PCT/IT1994/000086 patent/WO1995035116A1/en active IP Right Grant
-
1999
- 1999-10-29 GR GR990402777T patent/GR3031687T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO1995035116A1 (en) | 1995-12-28 |
DK0804223T3 (da) | 2000-01-24 |
DE69420872T2 (de) | 2000-01-13 |
US5898030A (en) | 1999-04-27 |
EP0804223A1 (en) | 1997-11-05 |
ATE184798T1 (de) | 1999-10-15 |
GR3031687T3 (en) | 2000-02-29 |
JP3829991B2 (ja) | 2006-10-04 |
DE69420872D1 (de) | 1999-10-28 |
EP0804223B1 (en) | 1999-09-22 |
JPH10504531A (ja) | 1998-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2139081T3 (es) | Composiciones farmaceuticas que contienen la hormona humana del crecimiento. | |
IL112112A0 (en) | Peptide derivatives and pharmaceutical compositions containing them | |
RU94046291A (ru) | Способ профилактики и лечения периферической невропатии, композиция, содержащая инсулин-подобный фактор роста i | |
PL315114A1 (en) | Compounds exhibiting properties of releasing growth hormones | |
IL111861A (en) | Phenyl-n-substituted azabicycloalkene derivatives and pharmaceutical compositions containing them | |
SE8804629D0 (sv) | New therapeutically active compounds | |
GR1001597B (el) | Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών. | |
IL126235A (en) | Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use | |
HUT57204A (en) | Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them | |
HU9301726D0 (en) | Compounds and preparatives hindering resorption of bones | |
SE9403389D0 (sv) | Pharmaceutical composition containing derivattves of sex hormones | |
NO952987L (no) | Sårhelende blanding | |
BR9306870A (pt) | Derivados farmacologicamente ativos de (aminometila terciária) - benzenometanol | |
ATE184489T1 (de) | Behandlung fehlender milchabsonderung beim menschen | |
EP0316639A3 (en) | Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient | |
ATE153859T1 (de) | Somatotropin zur erhoehung der reproduktiven leistung in rinder | |
DE69032591D1 (de) | Physiologisch aktive peptide und den calcium-metabolismus regulierende arzneimittel, die genannte peptide als wirkungsvollen bestandteil enthalten | |
JO1519B1 (en) | New compounds (new benzimidazole derivatives are effective as ulcers) | |
IT1255678B (it) | Composizioni farmaceutiche per la somministrazione di paratormone, suoi frammenti biologicamente attivi o peptidi correlati per via rettale. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 804223 Country of ref document: ES |